India's Biotech Department Steps In To Boost Biosimilars Programs Of Indian Companies
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - Realizing the importance of developing inexpensive biotech treatments, India's Department of Biotechnology has for the first time invited proposals from Indian companies to work together on the development of biosimilar products